Showing results (1-10 of 5,429) with videos related to
Sort By:
Pageof 543
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunodetectionS M Larson, C Divgi, A Scott, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibodyF Daghighian, E Barendswaard, S Welt, et al.European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.Cancer Research|February 1, 1990
Radioimmunodetection of hepatic metastases from human colon cancer in nude mice with a gamma-detecting probeM Rivoire, K Yoshida, C Divgi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.Cancer Research|February 1, 1990
Radiolocalization of monoclonal antibodies in hepatic metastases from human colon cancer in congenitally athymic miceK Yoshida, M Rivoire, C Divgi, et al.Medical Physics|February 1, 1997
An investigation of the physical characteristics of 66Ga as an isotope for PET imaging and quantificationM C Graham, K S Pentlow, O Mawlawi, et al.Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Accuracy of FDG-PET in Gastric Cancer. Preliminary ExperienceH W.D. Yeung, H Macapinlac, M Karpeh, et al.Thyroid : Official Journal of the American Thyroid Association|March 16, 2000
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogueR J Robbins, R H Hill, W Wang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myelomaA M el-Shirbiny, H Yeung, M Imbriaco, et al.Pageof 543